Geron

3 followers

‌

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Industries

Headquarters

Stage

Employees

Links

Org chart

John A. Scarlett

Chairman, President & CEO

John A. Scarlett

Collapse

Andrew J. Grethlein

EVP & COO

Edward Koval

EVP & Chief Business Officer

Michelle Robertson

Executive Vice President, CFO & Treasurer

Anil Kapur

EVP, Corporate Strategy & Chief Commercial Officer

Melissa A. Kelly Behrs

EVP, Business Operations & Chief Alliance Officer

Faye Feller

EVP, Chief Medical Officer

Scott A. Samuels

EVP, CLO & Corporate Secretary

Teams

View all

CEO and Executive Team

6 members

Leadership Team

6 members

Board of Directors

6 members

Discover similar companies

Columbia Care

2 followers

Travere Therapeutics

1 follower

Myovant Sciences

2 followers

MeiraGTx

1 follower

Cytokinetics

8 followers